BDBM737989 4-cyclobutyl-7-(2-((6-ethyl-1,2,3,4- tetrahydroisoquinolin-7-yl)amino)- 5-(trifluoromethyl)pyrimidin-4-yl)- 3,4-dihydrothieno[2,3- f][1,4]thiazepin-5(2H)-one 1,1- dioxide::US20250144094, Example 221

SMILES CCc1cc2c(cc1Nc1ncc(C(F)(F)F)c(-c3cc4c(s3)C(=O)N(C3CCC3)CCS4(=O)=O)n1)CNCC2

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 737989   

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737989(4-cyclobutyl-7-(2-((6-ethyl-1,2,3,4- tetrahydroiso...)
Affinity DataIC50: 5nMAssay Description:Table 4: ULK1 inhibitor potency was determined using the luminescent ADP Glo Kinase Assay (Promega), a universal ADP detection system that measures k...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent